BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to A-375 cell line is 41
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOTCH4 | 7884 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 0.0042 | 27234159 |
| CD44 | 1681 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 1 | 29693169 |
| CD44 | 1681 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 1 | 29693169 |
| CD44 | 1681 | LTM | Skin Cancer | NA | A-375 | NA | SFA and Western Blotting | NA | 0.48 | 1 | 30717768 |
| CD44 | 1681 | LTM | Skin Cancer | NA | A-375 | NA | FACs | NA | 0.48 | 1 | 26208390 |
| CD44 | 1681 | LTM | Skin Cancer | NA | A-375 | NA | FACs | NA | 0.48 | 1 | 27476721 |
| CD44 | 1681 | LTM | Skin Cancer | NA | A-375 | NA | FACs | NA | 0.48 | 1 | 29049740 |
| NANOG | 20857 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.5461 | 29693169 |
| NANOG | 20857 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 29693169 |
| NANOG | 20857 | LTM | Skin Cancer | NA | A-375 | NA | Western Blotting and SFA | NA | 0.48 | 0.5461 | 27566591 |
| NANOG | 20857 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.5461 | 30558661 |
| POU5F1 | 9221 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.6448 | 29693169 |
| POU5F1 | 9221 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 29693169 |
| POU5F1 | 9221 | LTM | Skin Cancer | NA | A-375 | NA | SFA and Western Blotting | NA | 0.48 | 0.6448 | 30717768 |
| POU5F1 | 9221 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 30558661 |
| POU5F1 | 9221 | LTM | Skin Cancer | NA | A-375 | NA | SP assay followed by RT-PCR | NA | 0.48 | 0.6448 | 30522558 |
| PROM1 | 9454 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.7582 | 29693169 |
| PROM1 | 9454 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.7582 | 29693169 |
| PROM1 | 9454 | LTM | Skin Cancer | NA | A-375 | NA | Western Blotting and FACs followed by SFA | NA | 0.48 | 0.7582 | 29408459 |
| PROM1 | 9454 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.7582 | 30558661 |
| PROM1 | 9454 | LTM | Skin Cancer | NA | A-375 | NA | FACs | NA | 0.48 | 0.7582 | 27476721 |
| PROM1 | 9454 | LTM | Skin Cancer | NA | A-375 | NA | FACs | NA | 0.48 | 0.7582 | 29049740 |
| SOX2 | 11195 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.5695 | 29693169 |
| SOX2 | 11195 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 29693169 |
| SOX2 | 11195 | LTM | Skin Cancer | NA | A-375 | NA | SP assay followed by RT-PCR | NA | 0.48 | 0.5695 | 30522558 |
| ALDH1A1 | 402 | LTM | Skin Cancer | NA | A-375 | NA | Western Blotting and ALDEFLUOR assay followed by SFA | NA | 0.4 | 0.684 | 29408459 |
| ALDH1A1 | 402 | LTM | Skin Cancer | NA | A-375 | NA | ALDEFLUOR assay and SFA | NA | 0.4 | 0.684 | 27566591 |
| ALDH1A1 | 402 | LTM | Skin Cancer | NA | A-375 | NA | ALDEFLUOR assay followed by CFA | NA | 0.4 | 0.684 | 29049740 |
| ABCB5 | 46 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0085 | 26693692 |
| EPCAM | 11529 | LTM | Skin Cancer | NA | A-375 | NA | SFA and Western Blotting | NA | 0.28 | 0.211 | 30717768 |
| EZH2 | 3527 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0074 | 26693692 |
| KIT | 6342 | LTM | Skin Cancer | NA | A-375 | NA | SFA and Western Blotting | NA | 0.28 | 0.018 | 30717768 |
| NGFR | 7809 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.018 | 26693692 |
| NGFR | 7809 | LTM | Skin Cancer | NA | A-375 | NA | FACs | NA | 0.28 | 0.018 | 27476721 |
| SCD | 10571 | LTM | Skin Cancer | NA | A-375 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0127 | 30558661 |
| ABCG2 | 74 | LTM | Skin Cancer | NA | A-375 | NA | FACs | NA | 0.12 | 0.1739 | 26208390 |
| ABCG2 | 74 | LTM | Skin Cancer | NA | A-375 | NA | FACs | NA | 0.12 | 0.1739 | 27476721 |
| ABCG5 | 13886 | LTM | Skin Cancer | NA | A-375 | NA | FACs | NA | 0.12 | 0.0021 | 27476721 |
| ALCAM | 400 | LTM | Skin Cancer | NA | A-375 | NA | FACs | NA | 0.12 | 0.0583 | 27476721 |
| FLT1 | 3763 | LTM | Skin Cancer | NA | A-375 | NA | FACs | NA | 0.12 | 0.0021 | 27476721 |
| MS4A1 | 7315 | LTM | Skin Cancer | NA | A-375 | NA | FACs | NA | 0.12 | 0.0085 | 27476721 |